Cooperative Agreements to USA Qualifying Metropolitan Areas for Improved HIV Prevention Programs

A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Implementation Sites

Agency

Federal

GrantWatch ID#

208640

Funding Source

U.S. Department of Health and Human Services (HHS) - Health Resources and Services Administration (HRSA)

CFDA Number: 93.899

Funding or PIN Number: HRSA-23-126

Geographic Focus

All USA

Important Dates

Deadline: 06/12/23 11:59 PM ET

Grant Description

Cooperative agreements to USA qualifying metropolitan areas to develop and implement new strategies for HIV prevention programs. Applicants are advised that required registrations may take up to one month to complete. Funding is intended to make testing easier to access and to reduce the stigma associated with HIV.

The purpose of this project is to develop, implement, and evaluate status neutral strategies within Ryan White HIV/AIDS Program (RWHAP) Part A jurisdictions for racial and ethnic minority subpopulations (i.e., Black women; Black, Latino, American Indian/Alaska Native gay, bisexual, and other men who have sex with men; transgender people; and people who use substances) who need HIV prevention services.

This project will focus on the prevention pathway, utilizing the existing RWHAP non-medical case management model (NMCM) and applying it to people who test negative for HIV and are at substantial risk for HIV, in order to assist in improving access to needed services. NMCM is the provision of a range of client centered activities focused on improving access to and retention in needed core medical and support services. NMCM provides coordination, guidance, and assistance in accessing medical, social, community, legal, financial, employment, vocational, and/or other needed services. NMCM may also include assisting eligible clients to obtain access to other public and private programs for which they may be eligible.

The goal of this project is to develop and implement a status neutral approach that:

Creates “one door” for both HIV prevention and treatment services.
Addresses institutionalized HIV stigma by integrating HIV prevention and care rather than supporting separate systems, which can deepen the divide between people with HIV and people who can benefit from HIV prevention services.
Enables people to know their status by making HIV testing, linkage to medical care, and testing for other medical conditions such as sexually transmitted infections (STIs) and Hepatitis C virus (HCV) more accessible and routine.

Recipient

Eligibility

Others (see text field entitled "Additional Eligibility Criteria" for clarification)

Additional Eligibility Criteria

RWHAP Part A recipients that continue to meet the status as an eligible area as defined in the statute are eligible to apply for these funds. Eligibility for RWHAP Part A grants is based in part on the number of confirmed AIDS cases within a statutorily specified metropolitan area. The Secretary uses the Office of Management and Budget’s (OMB) census-based definitions of a Metropolitan Statistical Area (MSA) in determining the geographic boundaries of a RWHAP metropolitan area. HHS utilizes the OMB geographic boundaries that were in effect when a jurisdiction was initially funded under RWHAP Part A. For all newly eligible areas, the boundaries are based on current OMB MSA boundary definitions.

An Eligible Metropolitan Area (EMA) must have more than AIDS 2,000 cases reported to and confirmed by the CDC during the most recent five calendar years; a Transitional Grant Area (TGA) must have at least 1,000 but fewer than 2,000 AIDS cases reported to and confirmed by the CDC during the most recent five calendar years for which such data are available. In addition, for three consecutive years, recipients must not have fallen below both the required incidence levels already specified and required prevalence levels (cumulative total of living AIDS cases reported to and confirmed by the CDC, as of December 31 of the most recent calendar year for which such data are available). For an EMA, the required prevalence is 3,000 living AIDS cases. For a TGA, the required prevalence is 1,500 or more living AIDS cases. However, for a TGA with five percent or less of the total amount from grants awarded to the area under Part A unobligated, as of the end of the most recent FY, the required prevalence is at least 1,400 and fewer than 1,500 living AIDS cases.

Ineligible

Multiple applications from an organization are not allowed.

For funding restrictions, see p. 26 of the NOFO in Attached Files.

Pre-Proposal Conference

HRSA has scheduled the following webinar:

Thursday, April 27, 2023
2 p.m. – 4 p.m. ET

Weblink: https://hrsa-gov.zoomgov.com/j/1605914943?pwd=cytPQkxSSW0vSVZnT2lKWGtvVytjQT09

Meeting ID: 160 591 4943
Passcode: Y7CJg161

Attendees without computer access or computer audio can use the dial-in information below:

Call-In Number: 833 568 8864
Meeting ID: 160 591 4943
Passcode: 08077130

Pre-Application Information

The application due date under this NOFO is June 12, 2023 at 11:59 p.m. ET. HRSA suggests you submit your application to Grants.gov at least 3 calendar days before the deadline to allow for any unforeseen circumstances.

HRSA requires you to apply electronically through Grants.gov.

Ensure your SAM.gov and Grants.gov registrations and passwords are current immediately. HRSA will not approve deadline extensions for lack of registration. Registration in all systems may take up to 1 month to complete.

General FAQs: https://www.hrsa.gov/grants/apply-for-a-grant/understand-the-grants-process

View this opportunity on Grants.gov: https://www.grants.gov/web/grants/view-opportunity.html?oppId=347475

For a list of relevant application documents, go to the Package tab (press Preview) on the Grants.gov link above.

Additional Funding Information

Estimated Total Program Funding:

$2,000,000

Number of Grants

Up to 4

Estimated Size of Grant

Up to $500,000 in year one, $375,000 in year two, and $375,000 in year three, per award subject to the availability of appropriated funds.

Term of Contract

Period of Performance: September 1, 2023 through August 31, 2026 (3 years)

Contact Information

You may request additional information and/or technical assistance regarding business, administrative, or fiscal issues related to this NOFO by contacting:

Beverly Smith Grants Management Specialist
Division of Grants Management Operations, OFAM
Health Resources and Services Administration
Phone: (301) 443-7065
Email: bsmith@hrsa.gov

You may request additional information regarding the overall program issues and/or technical assistance related to this NOFO by contacting:

Chrissy Abrahms Woodland
Director, Division of Metropolitan HIV/AIDS Programs
Attn: Ryan White HIV/AIDS Program, Part A
HIV/AIDS Bureau
Health Resources and Services Administration
Phone: 301 443-1373
Email: CAbrahms@hrsa.gov

For assistance with submitting the application in Grants.gov, contact Grants.gov 24 hours a day, 7 days a week, excluding federal holidays at:
Grants.gov Contact Center
Phone: 1-800-518-4726 (International callers dial 606-545-5035)
Email: support@grants.gov

RFP & Supporting Documents

Before starting your grant application, please review the funding source's website listed below for updates / changes / addendums / conferences / LOIs.

208640_HRSA-23-126_SNA_NOFO-Implementation_Sites_Final.pdf

Cooperative Agreements to USA Qualifying Metropolitan Areas for Improved HIV Prevention Programs

A Status Neutral Approach to Improve HIV Prevention and Health Outcomes for Racial and Ethnic Minorities – Implementation Sites

We have foundations for

We have grants for

Cookies